PROCEPT BioRobotics (PROCEPT BioRobotics) Gross Margin % : 56.21% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PROCEPT BioRobotics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. PROCEPT BioRobotics's Gross Profit for the three months ended in Mar. 2024 was $25.0 Mil. PROCEPT BioRobotics's Revenue for the three months ended in Mar. 2024 was $44.5 Mil. Therefore, PROCEPT BioRobotics's Gross Margin % for the quarter that ended in Mar. 2024 was 56.21%.

The historical rank and industry rank for PROCEPT BioRobotics's Gross Margin % or its related term are showing as below:

PRCT' s Gross Margin % Range Over the Past 10 Years
Min: -30.56 Med: 46.02 Max: 53.47
Current: 53.47

During the past 5 years, the highest Gross Margin % of PROCEPT BioRobotics was 53.47%. The lowest was -30.56%. And the median was 46.02%.

PRCT's Gross Margin % is ranked better than
50.38% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.295 vs PRCT: 53.47

PROCEPT BioRobotics had a gross margin of 56.21% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for PROCEPT BioRobotics was 0.00% per year.

PROCEPT BioRobotics Gross Margin % Historical Data

The historical data trend for PROCEPT BioRobotics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PROCEPT BioRobotics Gross Margin % Chart

PROCEPT BioRobotics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

-30.56

-16.26

46.02

49.44

52.17

PROCEPT BioRobotics Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Margin %	Get a 7-Day Free Trial												51.18	55.67	53.77	48.77	56.21

Competitive Comparison of PROCEPT BioRobotics's Gross Margin %

For the Medical Devices subindustry, PROCEPT BioRobotics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PROCEPT BioRobotics's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PROCEPT BioRobotics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where PROCEPT BioRobotics's Gross Margin % falls into.

PROCEPT BioRobotics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

PROCEPT BioRobotics's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	71	/	136.191
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(136.191 - 65.142)	/	136.191
	=	52.17 %

PROCEPT BioRobotics's Gross Margin for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )	=	Gross Profit (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	25	/	44.539
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(44.539 - 19.505)	/	44.539
	=	56.21 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

PROCEPT BioRobotics (NAS:PRCT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PROCEPT BioRobotics had a gross margin of 56.21% for the quarter that ended in Mar. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

PROCEPT BioRobotics Gross Margin % Related Terms

Thank you for viewing the detailed overview of PROCEPT BioRobotics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PROCEPT BioRobotics (PROCEPT BioRobotics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PROCEPT BioRobotics Corp (NAS:PRCT) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 Island Drive, Redwood, CA, USA, 94065

Website

https://www.procept-biorobotics.com

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Executives

Alaleh Nouri	officer: SVP, GEN COUNSEL, CORP. SEC.	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Kevin Waters	officer: Senior VP, CFO	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Wood Morgan Colby	director	C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CA 94065
Reza Zadno	director, officer: President, CEO	2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Hisham Shiblaq	officer: SVP, Commercial Operations	C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CITY CA 94065
Thomas M Krummel	director	C/O CALIFORNIA WATER SERVICE GROUP, 1720 N. FIRST STREET, SAN JOSE CA 95118
Viking Global Investors Lp	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Opportunities Parent Gp Llc	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Dragsa 88 Llc	10 percent owner	55 RAILROAD AVE, GREENWICH CT 06830
Rose Sharon Shabet	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Opportunities Illiquid Investments Sub-master Lp	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Opportunities Gp Llc	10 percent owner	55 RAILROAD AVENUE, GREENWICH CT 06830
Viking Global Opportunities Portfolio Gp Llc	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
David C. Ott	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901